IGM Biosciences, Inc.
NASDAQ:IGMS
6.37 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.516 | 1.254 | 0.497 | 0.651 | 0.509 | 0.448 | 0.522 | 0.372 | 0.331 | 0.366 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 2.276 | 2.176 | 2.181 | 2.259 | 3.518 | 2.987 | 3.222 | 2.622 | 2.533 | 2.225 | 2.178 | 1.953 | 2.248 | 1.345 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0.516 | -1.022 | -1.679 | -1.53 | -1.75 | -3.07 | -2.465 | -2.85 | -2.291 | -2.167 | -2.225 | -2.178 | -1.953 | -2.248 | -1.345 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 1 | -0.815 | -3.378 | -2.35 | -3.438 | -6.853 | -4.722 | -7.661 | -6.921 | -5.921 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 46.142 | 39.686 | 43.815 | 52.009 | 54.762 | 55.673 | 50.894 | 45.018 | 48.179 | 47.218 | 38.875 | 39.169 | 34.196 | 30.089 | 23.572 | 19.599 | 15.829 | 15.019 | 14.583 | 12.763 | 8.279 | 8.303 | 5.912 | 7.814 | 5.172 | 2.988 | 2.988 |
| General & Administrative Expenses
| 18.761 | 10.649 | 10.538 | 11.58 | 12.507 | 12.983 | 13.002 | 11.618 | 12.664 | 12.372 | 13.081 | 11.511 | 10.003 | 8.649 | 8.134 | 5.14 | 4.732 | 4.388 | 3.99 | 3.174 | 2.394 | 2.228 | 1.445 | 1.232 | 1.373 | 0.612 | 0.612 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 18.761 | 10.649 | 10.538 | 11.58 | 12.507 | 12.983 | 13.002 | 11.618 | 12.664 | 12.372 | 13.081 | 11.511 | 10.003 | 8.649 | 8.134 | 5.14 | 4.732 | 4.388 | 3.99 | 3.174 | 2.394 | 2.228 | 1.445 | 1.232 | 1.373 | 0.612 | 0.612 |
| Other Expenses
| 0 | -41.962 | 0 | 0.02 | 0 | 0 | -0.02 | -0.058 | 0 | 0.629 | 0.062 | 0.038 | 0.035 | 0.024 | 0.062 | 0.117 | 0.291 | 0.568 | 0.949 | 1.122 | 0.501 | -0.145 | -0.113 | -0.007 | 0.028 | 0 | 0 |
| Operating Expenses
| 64.903 | 50.335 | 54.353 | 63.589 | 67.269 | 68.656 | 63.896 | 56.636 | 60.843 | 59.59 | 51.956 | 50.68 | 44.199 | 38.738 | 31.706 | 24.739 | 20.561 | 19.407 | 18.573 | 15.937 | 10.673 | 10.531 | 7.357 | 9.046 | 6.545 | 3.571 | 3.571 |
| Operating Income
| -64.387 | -51.357 | -53.856 | -65.119 | -66.76 | -68.208 | -63.374 | -56.264 | -60.512 | -59.224 | -51.956 | -50.68 | -44.199 | -38.738 | -31.706 | -24.739 | -20.561 | -19.407 | -18.573 | -15.937 | -10.673 | -10.531 | -7.357 | -9.046 | -6.545 | -3.6 | -3.6 |
| Operating Income Ratio
| -124.781 | -40.955 | -108.362 | -100.029 | -131.159 | -152.25 | -121.406 | -151.247 | -182.816 | -161.814 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.957 | 3.455 | 4.04 | 4.666 | 5.011 | 3.894 | 4.152 | 3.688 | 2.475 | 0.629 | 0.062 | 0.038 | 0.035 | 0.024 | 0.062 | 0.117 | 0.291 | 0.568 | 0.949 | 1.122 | 0.501 | -0.145 | -0.113 | -0.007 | 0.028 | 0.03 | 0.03 |
| Income Before Tax
| -61.43 | -47.902 | -49.816 | -60.453 | -61.749 | -64.314 | -59.222 | -52.576 | -58.037 | -58.595 | -51.894 | -50.642 | -44.164 | -38.714 | -31.644 | -24.622 | -20.27 | -18.839 | -17.624 | -14.815 | -10.172 | -10.676 | -7.47 | -9.053 | -6.517 | -3.571 | -3.571 |
| Income Before Tax Ratio
| -119.05 | -38.199 | -100.233 | -92.862 | -121.314 | -143.558 | -113.452 | -141.333 | -175.338 | -160.096 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -2.176 | 0.242 | -0.24 | 0.109 | 0.087 | -4.379 | -2.475 | -0.629 | -0.062 | -1.303 | -0.858 | -0.835 | -0.672 | -0.312 | 0 | 0 | 0 | 1.022 | 1.203 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -61.43 | -47.902 | -49.816 | -60.695 | -61.989 | -64.423 | -59.309 | -48.197 | -55.562 | -57.966 | -51.832 | -50.642 | -44.164 | -38.714 | -31.644 | -24.622 | -20.27 | -18.839 | -17.624 | -14.815 | -10.172 | -10.676 | -7.47 | -9.053 | -6.517 | -3.571 | -3.571 |
| Net Income Ratio
| -119.05 | -38.199 | -100.233 | -93.233 | -121.786 | -143.801 | -113.619 | -129.562 | -167.861 | -158.377 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.01 | -0.79 | -0.83 | -1.01 | -1.04 | -1.43 | -1.33 | -1.09 | -1.26 | -1.32 | -1.53 | -1.5 | -1.32 | -1.16 | -0.95 | -0.79 | -0.66 | -0.62 | -0.58 | -0.49 | -2.41 | -19.08 | -16.86 | -20.67 | -14.88 | -8.15 | -8.15 |
| EPS Diluted
| -1.01 | -0.79 | -0.83 | -1.01 | -1.04 | -1.43 | -1.33 | -1.09 | -1.26 | -1.32 | -1.53 | -1.5 | -1.32 | -1.16 | -0.95 | -0.79 | -0.66 | -0.62 | -0.58 | -0.49 | -2.41 | -19.08 | -16.86 | -20.67 | -14.88 | -8.15 | -8.15 |
| EBITDA
| -62.08 | -49.081 | -51.68 | -63.447 | -64.501 | -66.035 | -61.71 | -54.366 | -59.003 | -57.78 | -50.732 | -49.377 | -43.104 | -37.325 | -31.033 | -24.427 | -20.313 | -19.164 | -18.351 | -15.937 | -10.516 | -10.386 | -7.243 | -8.959 | -6.474 | -3.54 | -3.54 |
| EBITDA Ratio
| -120.31 | -39.14 | -108.362 | -96.679 | -131.159 | -147.4 | -118.218 | -151.247 | -178.257 | -157.869 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |